Article from 18.12.2024 | Last changed: 17.06.2025
Environmental aspects of the authorisation of human medicinal pro
… Environmental aspects of the authorisation of human medicinal pro Versuchsaufbau … always be carried out. It follows a decision tree to identify products considered environmentally relevant, for which a more detailed Phase II risk assessment is …